1
Toorop, Myrthe M.A., Chen, Qingui, Tichelaar, Vladimir Y.I.G., Cannegieter, Suzanne C., Lijfering, Willem M.
Veröffentlicht in: Toorop , M M A , Chen , Q , Tichelaar , V Y I G , Cannegieter , S C & Lijfering , W M 2021 , ' Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation : A Dutch Nationwide Cohort Study ' , European Heart Journal , vol. 42 , no. 40 , pp. 4126-4137 . https://doi.org/10.1093/eurheartj/ehab421;
2021
Veröffentlicht in: Toorop , M M A , Chen , Q , Tichelaar , V Y I G , Cannegieter , S C & Lijfering , W M 2021 , ' Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation : A Dutch Nationwide Cohort Study ' , European Heart Journal , vol. 42 , no. 40 , pp. 4126-4137 . https://doi.org/10.1093/eurheartj/ehab421;
2021
2
3
de Jong, Lisa A, Dvortsin, Evgeni, Janssen, Kristel J., Postma, Maarten J.
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017
Veröffentlicht in: de Jong , L A , Dvortsin , E , Janssen , K J & Postma , M J 2017 , ' Cost-effectiveness Analysis for Apixaban in the Acute Treatment and Prevention of Venous Thromboembolism in the Netherlands ' , Clinical Therapeutics , vol. 39 , no. 2 , pp. 288-302 . https://doi.org/10.1016/j.clinthera.2016.12.012;
2017